Relationship of methylglyoxal-adduct biogenesis to LDL and triglyceride levels in diabetics

Life Sciences

Volumn 89, Issue 13-14, 2011, Pages 485-490

  Turk, Zdenka ^a   Čavlović Naglić, Maja ^a   Turk, Nikša ^b  

^a University of Zagreb   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

dicarbonyl intermediates; Advanced glycation process; Diabetes; Methylglyoxal adducts

Indexed keywords

ALBUMIN; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPERGLYCEMIC AGENT; INSULIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHYLGLYOXAL; STATIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BIOGENESIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE URINE LEVEL; DIABETES MELLITUS; GLYCEMIC CONTROL; HUMAN; HYPERLIPIDEMIA; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MICROALBUMINURIA; MULTIPLE REGRESSION; OXIDATIVE STRESS; TRIACYLGLYCEROL BLOOD LEVEL; URINE LEVEL;

ADULT; AGED; AGED, 80 AND OVER; CHOLESTEROL, LDL; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; HYPERLIPIDEMIAS; MIDDLE AGED; PYRUVALDEHYDE; TRIGLYCERIDES;

EID: 80052707653     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2011.07.021     Document Type: Article

References (26)

1. N. Ahmed, R. Babaei-Jadidi, S.K. Howell, P.J. Beisswenger, and P.J. Thornalley Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes Diabetologia 48 2005 1590 1603 (Pubitemid 41175513)
2. N. Ahmed, and J. Thornalley Advanced glycation endproducts: what is their relevance to diabetic complications? Diabetes Obes Metab 9 2007 233 245 (Pubitemid 46502041)
3. J.W. Baynes, and S.R. Thorpe Glycoxidation and lipoxidation in atherogenesis Free Radic Biol Med 28 2000 1708 1716 (Pubitemid 30628657)
4. P.J. Beisswenger, S.K. Howell, R.M. O'Dell, M.E. Wood, A.D. Touchette, and B.S. Szwergold α-Dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia Diabetes Care 24 2001 726 732 (Pubitemid 32888855)
5. P.J. Beisswenger, S.K. Howell, K. Smith, and B.S. Szwergold Glyceraldehyde-3-phosphate dehydrogenase activity as an independent modifier of methylglyoxal levels in diabetes Biochem Biophys Acta 1637 2003 98 106 (Pubitemid 36071602)
6. M. Brownlee The pathobiology of diabetic complications - a unifying mechanism Diabetes 54 2005 1615 1625 (Pubitemid 40770750)
7. J.A. Chavez, and S.A. Summers Lipid oversupply, selective insulin resistance, and lipotoxicity: Molecular mechanisms Biochim Biophys Acta Molec Cell Biol Lipids 1801 3 Special Issue SI 2010 252 265
8. F.J. Hidalgo, and R. Zamora Interplay between the Maillard reaction and lipid peroxidation in biochemical systems Ann NY Acad Sci 1043 2005 319 326 (Pubitemid 41123921)
9. G. Huebschmann, J.G. Regensteiner, H. Vlassara, and J.E. Reusch Diabetes and advanced glycoxidation end products Diabetes Care 29 2006 1420 1432 (Pubitemid 44125953)
10. M.P. Kalapos On the mammalian acetone metabolism: from chemistry to clinical implications Biochim Biophys Acta 1621 2003 122 139 (Pubitemid 36515094)
11. M.P. Kalapos The tandem of free radicals and methylglyoxal Chem Biol Interact 171 2008 251 271
12. A. Lapolla, R. Flamini, A.D. Vedova, A. Senesi, R. Reitano, and D. Fedele Glyoxal and methylglyoxal levels in diabetic patients: quantitative determination by a new GC/MS method Clin Chem Lab Med 41 2003 1166 1173 (Pubitemid 37265695)
13. A.C. McLellan, P.J. Thornalley, J. Benn, and P.H. Sonksen Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications Clin Sci 87 1994 21 29 (Pubitemid 24220267)
14. F. Moheimani, P.E. Morgan, D.M. van Reyk, and M.J. Davies Deleterious effects of reactive aldehydes and glycated proteins on macrophage proteasomal function: possible links between diabetes and atherosclerosis Biochim Biophys Acta 1802 2010 561 571
15. K. Nakayama, M. Nakayama, M. Iwabuchi, H. Terawaki, T. Sato, and M. Kohno Plasma alpha-oxoaldehyde levels in diabetic and nondiabetic chronic kidney disease patients Am J Nephrol 28 2008 871 878
16. I. Nemet, Z. Turk, L. Duvnjak, N. Car, and L. Varga-Defterdarović Humoral methylglyoxal level reflects glycemic fluctuation Clin Biochem 38 2005 379 383 (Pubitemid 40342868)
17. I. Nemet, L. Varga-Deftardarović, and Z. Turk Methylglyoxal in food and living organisms Mol Nutr Food Res 50 2006 1105 1117 (Pubitemid 46032199)
18. E. Nobecourt, M.J. Davies, B.E. Brown, L.K. Curtiss, D.J. Bonnet, and F. Charlton The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase Diabetologia 50 2007 643 653 (Pubitemid 46215509)
19. N. Rabbani, and P.J. Thornalley Glyoxalase in diabetes, obesity and related disorders Semin Cell Dev Biol 22 2011 309 317
20. F. Santilli, L. Bucciarelli, D. Noto, A.B. Cefalu, V. Davi, and E. Ferrante Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins Free Radic Biol Med 43 2007 1255 1262 (Pubitemid 47429934)
21. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care 26 2003 3160 3167
22. P.J. Thornalley Dicarbonyl intermediates in the Maillard reaction Ann NY Acad Sci 1043 2005 111 117 (Pubitemid 41123896)
23. S.R. Thorpe, and J.W. Baynes Maillard reaction products in tissue proteins: new products and new perspectives Amino Acids 25 2003 275 281 (Pubitemid 38041265)
24. Z. Turk, I. Nemet, L. Varga-Deftardarović, and N. Car Elevated level of methylglyoxal during diabetic ketoacidosis and its recovery phase Diabetes Metab 32 2006 176 180
25. Z. Turk, A. Vrdoljak, I. Mišur, A. Trešćec, and B. Benko Methylglyoxal-derivative advanced glycation endproducts: detection by competitive immunofluorometric assay and quantifying in serum and urine Clin Lab 55 2009 431 439
26. Z. Turk Glycotoxins, carbonyl stress and relevance to diabetes and its complications Physiol Res 59 2010 147 156